Typhoid IgG and IgM (S. typhi IgG + IgM) Rapid Test Kit |
|
abx092223-100l |
Abbexa |
100 µl |
EUR 650 |
Human IgG antibody Laboratories manufactures the imunology response igm and igg reagents distributed by Genprice. The Imunology Response Igm And Igg reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igm antibody. Other Imunology products are available in stock. Specificity: Imunology Category: Response Group: Igm And
Goat anti Human IgG, IgM and IgA (H&L) |
|
GenWay Biotech |
2 ml |
Ask for price |
|
|
Goat anti Human IgG, IgM and IgA (H&L) |
|
MyBiosource |
2mL |
EUR 630 |
Goat anti Human IgG, IgM and IgA (H&L) |
|
MyBiosource |
5x2mL |
EUR 2670 |
Human Cytomegalovirus IgG/IgM, Toxoplasma IgG/IgM, Rubella IgG (CMV + TOXO IgG/IgM, RV IgG) Rapid Test Kit |
|
Abbexa |
100 µl |
EUR 262.5 |
Human Cytomegalovirus IgG/IgM, Toxoplasma IgG/IgM, Rubella IgG (CMV + TOXO IgG/IgM, RV IgG) Rapid Test Kit |
|
Abbexa |
1 ml |
Ask for price |
Human Cytomegalovirus IgG/IgM, Toxoplasma IgG/IgM, Rubella IgG (CMV + TOXO IgG/IgM, RV IgG) Rapid Test Kit |
|
Abbexa |
200 µl |
EUR 425 |
Human IgA, IgG and IgM AssayLite Multiplex Fluorescent Immunoassay Kit |
|
AssayPro |
96 Well Plate |
EUR 1472.4 |
Igm And information
RAD51 (Prognostic and Response to Chemotherapy Marker) |
|
MBS4380676-01mgWithoutBSAAzideat1mgmL |
MyBiosource |
0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 405 |
RAD51 (Prognostic and Response to Chemotherapy Marker) |
|
MBS4380676-5x01mgWithBSAAzideat02mgmL |
MyBiosource |
5x0.1mg(WithBSA&Azideat0.2mg/mL) |
EUR 1725 |
RAD51 (Prognostic and Response to Chemotherapy Marker) |
|
MBS4380676-5x01mgWithoutBSAAzideat1mgmL |
MyBiosource |
5x0.1mg(WithoutBSA&Azideat1mg/mL) |
EUR 1725 |
Rabbit Anti-Human serum deprivation response (SDPR) IgG (aff pure) |
|
AB-23034-A |
Alpha Diagnostics |
100ug |
EUR 578.4 |
RAD51 (Prognostic and Response to Chemotherapy Marker)(RAD51/2701), 1mg/mL |
|
BNUM2701-50 |
Biotium |
1uL |
EUR 396 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
RAD51 (Prognostic and Response to Chemotherapy Marker)(RAD51/2702), 1mg/mL |
|
BNUM2702-50 |
Biotium |
1uL |
EUR 396 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
RAD51 (Prognostic and Response to Chemotherapy Marker)(RAD51/2753), 1mg/mL |
|
BNUM2753-50 |
Biotium |
1uL |
EUR 396 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
RAD51 (Prognostic and Response to Chemotherapy Marker)(RAD51/2765), 1mg/mL |
|
BNUM2765-50 |
Biotium |
1uL |
EUR 396 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
RAD51 (Prognostic and Response to Chemotherapy Marker)(RAD51/2701), 0.2mg/mL |
|
BNUB2701-100 |
Biotium |
1uL |
EUR 225 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
RAD51 (Prognostic and Response to Chemotherapy Marker)(RAD51/2701), 0.2mg/mL |
|
BNUB2701-500 |
Biotium |
1uL |
EUR 485 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
RAD51 (Prognostic and Response to Chemotherapy Marker)(RAD51/2702), 0.2mg/mL |
|
BNUB2702-100 |
Biotium |
1uL |
EUR 225 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
RAD51 (Prognostic and Response to Chemotherapy Marker)(RAD51/2702), 0.2mg/mL |
|
BNUB2702-500 |
Biotium |
1uL |
EUR 485 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
RAD51 (Prognostic and Response to Chemotherapy Marker)(RAD51/2753), 0.2mg/mL |
|
BNUB2753-100 |
Biotium |
1uL |
EUR 225 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
RAD51 (Prognostic and Response to Chemotherapy Marker)(RAD51/2753), 0.2mg/mL |
|
BNUB2753-500 |
Biotium |
1uL |
EUR 485 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
RAD51 (Prognostic and Response to Chemotherapy Marker)(RAD51/2765), 0.2mg/mL |
|
BNUB2765-100 |
Biotium |
1uL |
EUR 225 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
RAD51 (Prognostic and Response to Chemotherapy Marker)(RAD51/2765), 0.2mg/mL |
|
BNUB2765-500 |
Biotium |
1uL |
EUR 485 |
|
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
Serum response factor |
|
AP87612 |
SAB |
1mg |
EUR 2640 |
|
|
